Ademetionine (S-adenosylmethionine) neuropharmacology: implications for drug therapies in psychiatric and neurological disorders

Author： Bottiglieri T.  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.6, Iss.4, 1997-04, pp. : 417-426

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Ademetionine (S-Adenosylmethionine) in Cyclosporin-Induced Cholestasis

By Neri S.  

Clinical Drug Investigation, Vol. 22, Iss. 3, 2002-03 ,pp. : 191-195

Adis International

Access to resources Recommend Favorite

Astrocytic Adrenoceptors: A Major Drug Target in Neurological and Psychiatric Disorders?

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 3, Iss. 3, 2004-06 ,pp. : 239-268

Bentham Science Publishers

Access to resources Recommend Favorite

Radiopharmaceuticals in Neurological and Psychiatric Disorders

By  

Current Clinical Pharmacology, Vol. 3, Iss. 2, 2008-05 ,pp. : 99-107

Bentham Science Publishers

Access to resources Recommend Favorite

The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders

By van der Stelt M.   Di Marzo V.  

European Journal of Pharmacology, Vol. 480, Iss. 1, 2003-11 ,pp. : 133-150

Elsevier

Access to resources Recommend Favorite

The Role of mGlu Receptors in Hippocampal Plasticity Deficits in Neurological and Psychiatric Disorders: Implications for Allosteric Modulators as Novel Therapeutic Strategies

By  

Current Neuropharmacology, Vol. 14, Iss. 5, 2016-06 ,pp. : 455-473

Bentham Science Publishers

Access to resources Recommend Favorite